Northwestern Mutual Wealth Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $710 | Hold |
500
| – | – | ﹤0.01% | 3419 |
|
|
2025
Q1 | $765 | Hold |
500
| – | – | ﹤0.01% | 3324 |
|
|
2024
Q4 | $1.24K | Hold |
500
| – | – | ﹤0.01% | 3264 |
|
|
2024
Q3 | $575 | Hold |
500
| – | – | ﹤0.01% | 3329 |
|
|
2024
Q2 | $550 | Hold |
500
| – | – | ﹤0.01% | 3278 |
|
|
2024
Q1 | $620 | Hold |
500
| – | – | ﹤0.01% | 3256 |
|
|
2023
Q4 | $525 | Hold |
500
| – | – | ﹤0.01% | 3270 |
|
|
2023
Q3 | $3.43K | Hold |
500
| – | – | ﹤0.01% | 2844 |
|
|
2023
Q2 | $5.19K | Hold |
500
| – | – | ﹤0.01% | 2770 |
|
|
2023
Q1 | $4.05K | Hold |
500
| – | – | ﹤0.01% | 2805 |
|
|
2022
Q4 | $7.88K | Hold |
500
| – | – | ﹤0.01% | 2584 |
|
|
2022
Q3 | $8K | Hold |
500
| – | – | ﹤0.01% | 2513 |
|
|
2022
Q2 | $7K | Hold |
500
| – | – | ﹤0.01% | 2612 |
|
|
2022
Q1 | $9K | Hold |
500
| – | – | ﹤0.01% | 2558 |
|
|
2021
Q4 | $7K | Hold |
500
| – | – | ﹤0.01% | 2665 |
|
|
2021
Q3 | $9K | Hold |
500
| – | – | ﹤0.01% | 2487 |
|
|
2021
Q2 | $9K | Hold |
500
| – | – | ﹤0.01% | 2451 |
|
|
2021
Q1 | $13K | Hold |
500
| – | – | ﹤0.01% | 2201 |
|
|
2020
Q4 | $3K | Hold |
500
| – | – | ﹤0.01% | 2442 |
|
|
2020
Q3 | $1K | Hold |
500
| – | – | ﹤0.01% | 2414 |
|
|
2020
Q2 | $1K | Hold |
500
| – | – | ﹤0.01% | 2263 |
|
|
2020
Q1 | $1K | Buy |
+500
| New | +$1K | ﹤0.01% | 2341 |
|